Literature DB >> 15876840

Use of segmental multifrequency bioimpedance spectroscopy in hemodialysis.

Nathan W Levin1, Fansan Zhu, Eric Seibert, Claudio Ronco, Martin K Kuhlmann.   

Abstract

Whole body bioimpedance (BI) appears to be accurate and reproducible in the assessment of body composition, but does not appear useful for estimation of dry weight. Segmental BI has been used for the assessment of muscle mass in body segments, such as arms or legs and may be useful for rehabilitation studies. A promising new development is the application of segmental BI for dry weight determination. Changes in extracellular volume of the calf are recorded continuously during HD, thereby allowing the detection of a time-point at which no further volume is removed from the calf despite ongoing ultrafiltration (UF). Continuation of UF beyond this point is associated with an increased risk of intradialytic hypotension. This new technology may help optimizing the prescription of dry weight and UF rates in hemodialysis patients.

Entities:  

Mesh:

Year:  2005        PMID: 15876840     DOI: 10.1159/000085482

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  3 in total

1.  Changes in arterial stiffness following dialysis in relation to overhydration and to endothelial function.

Authors:  Simona Hogas; Serban Ardeleanu; Liviu Segall; Dragomir Nicolae Serban; Ionela Lacramioara Serban; Mihai Hogas; Mugurel Apetrii; Mihai Onofriescu; Radu Sascau; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-03-19       Impact factor: 2.370

2.  Probing the dry weight by bioimpedance: the resistance stabilization test.

Authors:  Carlo Basile; Pasquale Libutti; Piero Lisi; Luigi Rossi; Carlo Lomonte
Journal:  J Nephrol       Date:  2014-12-06       Impact factor: 3.902

3.  Disordered aldosterone-volume relationship in end-stage kidney disease.

Authors:  Andrew S Bomback; Abhijit V Kshirsagar; Maria E Ferris; Philip J Klemmer
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2009-10-28       Impact factor: 1.636

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.